top of page
Search
Key Patent Issued in the US
SCOHIA PHARMA and Kuria Therapeutics Announce Issuance of Key Patent Covering Novel Nrf2 Activator KANAGAWA, Japan & LITTLE ROCK,...
Keith Ward
Jan 5, 2023
Kuria Granted Exclusive Worldwide Rights to Novel Nrf2 Activator
Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2...
Keith Ward
Jun 27, 2022
bottom of page